Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration

[1]  P. Thuras,et al.  Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans , 2016, Antimicrobial Agents and Chemotherapy.

[2]  S. Gatermann,et al.  Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data – The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory , 2016, PloS one.

[3]  A. Gardner,et al.  Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies , 2015, BMC Infectious Diseases.

[4]  J. Fierer,et al.  Clinical and microbiological determinants of infection after transrectal prostate biopsy. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  James R. Johnson,et al.  Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli , 2015, Open forum infectious diseases.

[6]  P. Polgreen,et al.  Transrectal Prostate Biopsy-Associated Prophylaxis and Infectious Complications: Report of a Query to the Emerging Infections Network of the Infectious Diseases Society of America , 2015, Open forum infectious diseases.

[7]  W. Bilker,et al.  Clinical and Molecular Epidemiology of Escherichia coli Sequence Type 131 among Hospitalized Patients Colonized Intestinally with Fluoroquinolone-Resistant E. coli , 2014, Antimicrobial Agents and Chemotherapy.

[8]  James R. Johnson,et al.  A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131 , 2014, Antimicrobial Agents and Chemotherapy.

[9]  M. Kuskowski,et al.  Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Maliha Aziz,et al.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. , 2013, The Journal of infectious diseases.

[11]  C. Lohse,et al.  Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts , 2013, Infection Control & Hospital Epidemiology.

[12]  J. Karlowsky,et al.  In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010 , 2012, Antimicrobial Agents and Chemotherapy.

[13]  M. Achtman,et al.  Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. , 2011, The Journal of antimicrobial chemotherapy.

[14]  Richard Colgan,et al.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Kuskowski,et al.  Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  G. Peirano,et al.  Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. , 2010, International journal of antimicrobial agents.

[17]  E. P. Dellinger,et al.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Jessina C. McGregor,et al.  Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study , 2008, BMC infectious diseases.

[19]  S. Blot,et al.  Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. , 2007, The Journal of antimicrobial chemotherapy.

[20]  B. Lee,et al.  Fluoroquinolone-resistant Escherichia coli Carriage in Long-Term Care Facility , 2005, Emerging infectious diseases.

[21]  Sung-Han Kim,et al.  Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[22]  Stephen F Eckel,et al.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[24]  V. Valtonen,et al.  Prognostic factors associated with improved outcome ofEscherichia coli bacteremia in a Finnish university hospital , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  F. Tubau,et al.  Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  D. Paterson,et al.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. , 2011, The Journal of antimicrobial chemotherapy.

[27]  L. Martínez-Martínez,et al.  Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. , 2007, The Journal of antimicrobial chemotherapy.

[28]  S. Walter,et al.  Risk factors for resistance to antimicrobial agents among nursing home residents. , 2003, American journal of epidemiology.